The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Elrifi Ivor | Chief Executive Officer | Buy(P) | 238K | $1.00 | $238K |
| Aug 4, 2026 | Elrifi Ivor | Chief Executive Officer | Buy(P) | 84K | $0.97 | $81K |
| Aug 3, 2026 | Elrifi Ivor | Chief Executive Officer | Buy(P) | 667K | $1.00 | $667K |
| Jul 21, 2026 | Cerrone Gabriele M | Director, 10% Owner | Buy(P) | 42K | $0.99 | $42K |
| Jun 12, 2026 | Cerrone Gabriele M | Director, 10% Owner | Buy(P) | 15K | $1.11 | $17K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Tiziana Life Sciences Ltd, SEC CIK 0001723069. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under TLSA and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for TLSA